Finance

Roʻyxatlar
Nega 688068 tushdi 4,05%?
Batafsil oʻrganish
688068:SHA
Beijing Hotgen Biotech Co Ltd
72,73 CN¥
-4,05%
(-3,07) 1K
16-okt, 15:00:01 (GMT+8)  ·   CNY
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
688068 tikeri uchun statistika yaratilmoqda...
Ochish
77,88 CN¥
Yuqori
79,49 CN¥
Past
71,68 CN¥
Bozor kapitali
7,15 mlrd
Oʻrtacha hajm
2,28 mln
Hajmi
3,10 mln
52 haftalik eng yuqori
214,78 CN¥
52 haftalik eng past
71,68 CN¥
Aksiya boʻyicha daromad
-3,00 CN¥
Xodimlar soni
1 ming
Ochish
77,88 CN¥
Yuqori
79,49 CN¥
Past
71,68 CN¥
Bozor kapitali
7,15 mlrd
Oʻrtacha hajm
2,28 mln
Hajmi
3,10 mln
52 haftalik eng yuqori
214,78 CN¥
52 haftalik eng past
71,68 CN¥
Aksiya boʻyicha daromad
-3,00 CN¥
Xodimlar soni
1 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification. Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
Beijing Hotgen Biotech Co Ltd haqida
CEO-
Xodimlar soni1,04 ming
Asos solingan23-iyn, 2005
Bosh ofislar-
Sektor-
Avvalgi hisobotlarBarcha qiymatlar – CNY
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – CNY
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
105,80 mln
95,17 mln
116,03 mln
151,72 mln
Sotilgan mahsulotning tannarxi
49,91 mln
40,31 mln
55,11 mln
36,50 mln
Daromad narxi
49,91 mln
40,31 mln
55,11 mln
36,50 mln
Tadqiqot va ishlanmalarga xarajatlar
19,65 mln
94,81 mln
49,10 mln
46,03 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
83,78 mln
99,31 mln
97,60 mln
127,34 mln
Operatsion xarajatlar
98,59 mln
204,82 mln
143,51 mln
186,68 mln
Jami operatsion xarajatlar
148,50 mln
245,13 mln
198,62 mln
223,17 mln
Operatsion daromad
-42,70 mln
-149,96 mln
-82,59 mln
-71,46 mln
Boshqa nooperatsion daromad
-273,76 ming
2,19 mln
-2,39 mln
2,09 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-20,92 mln
-155,14 mln
-82,67 mln
-76,94 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-28,82 mln
-122,01 mln
-69,59 mln
-76,99 mln
Daromad soligʻi boʻyicha xarajat
4,59 mln
-6,98 mln
-5,78 ming
-796,34 ming
Amaldagi soliq stavkasi
-21,96%
4,50%
0,01%
1,03%
Boshqa operatsion xarajatlar
-5,37 mln
6,99 mln
-2,96 mln
3,17 mln
Sof foyda
-24,96 mln
-107,09 mln
-68,06 mln
-58,07 mln
Sof foyda marjasi
-23,59%
-112,52%
-58,66%
-38,27%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
14,98 mln
35,99 mln
15,44 mln
3,94 mln
Foizlarni toʻlash xarajatlari
-289,66 ming
-7,96 mln
-46,88 ming
-7,63 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
14,69 mln
28,03 mln
15,39 mln
-3,69 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-21,62 mln
-129,90 mln
-62,53 mln
-53,46 mln
Aktivlarni sotishdan olingan foyda yoki zarar
601,43 ming
-579,43 ming
-
6,83 ming
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari